Genentech advanced the collaboration’s first neuroscience target into a joint early discovery program, providing early evidence that Recursion’s platform can generate novel, biologically validated targets for drug discoveryREC-4881 (MEK1/2 inhibitor): Additional Phase 2 data in Familial Adenomatous Polyposis (FAP) to be presented at the Presidential…
Canada News
By Staff The Canadian Press Posted August 4, 2026 6:51 pm 1 min read Descrease article font size Increase article font size Search crews…
Lifestyle
WASHINGTON (AP) — You’ve likely heard it since childhood: Don’t scratch that bug bite or rash, you’ll make it worse.…
Tech & Innovation
The brand trip is a right of passage for influencers. It’s a mark of legitimacy that a sponsor wants to invite them on an all-expenses-paid vacation,…